TCA
GILD icon

Transcend Capital Advisors’s Gilead Sciences GILD Stock Holding History

Transcend Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$924K Buy
6,633
+128
+2% +$17.9K 0.07% 247
2025
Q4 		$798K Buy
6,505
+301
+5% +$36.6K 0.06% 272
2025
Q3 		$689K Buy
6,204
+416
+7% +$47.3K 0.05% 318
2025
Q2 		$642K Buy
5,788
+318
+6% +$33.8K 0.05% 297
2025
Q1 		$613K Sell
5,470
-149
-3% -$15.4K 0.04% 324
2024
Q4 		$519K Sell
5,619
-2,787
-33% -$251K 0.04% 342
2024
Q3 		$705K Buy
8,406
+89
+1% +$6.79K 0.05% 321
2024
Q2 		$571K Buy
8,317
+45
+0.5% +$3K 0.04% 326
2024
Q1 		$606K Buy
8,272
+1,614
+24% +$124K 0.05% 293
2023
Q4 		$539K Buy
6,658
+72
+1% +$5.6K 0.05% 297
2023
Q3 		$494K Buy
6,586
+490
+8% +$37.7K 0.05% 291
2023
Q2 		$470K Buy
6,096
+95
+2% +$7.58K 0.04% 310
2023
Q1 		$498K Sell
6,001
-18,980
-76% -$1.57M 0.05% 290
2022
Q4 		$2.14M Sell
24,981
-1,540
-6% -$122K 0.23% 108
2022
Q3 		$1.64M Buy
26,521
+510
+2% +$32.2K 0.18% 134
2022
Q2 		$1.61M Buy
26,011
+88
+0.3% +$5.45K 0.17% 144
2022
Q1 		$1.54M Buy
25,923
+8,296
+47% +$530K 0.14% 167
2021
Q4 		$1.28M Hold
17,627
– – 0.11% 191
2021
Q3 		$1.19M Sell
17,627
-128
-0.7% -$8.99K 0.11% 196
2021
Q2 		$1.22M Sell
17,755
-230
-1% -$15.4K 0.18% 134
2021
Q1 		$1.16M Sell
17,985
-2,261
-11% -$146K 0.14% 162
2020
Q4 		$1.18M Sell
20,246
-19
-0.1% -$1.15K 0.16% 148
2020
Q3 		$1.28M Buy
20,265
+4,627
+30% +$321K 0.23% 97
2020
Q2 		$1.2M Sell
15,638
-3,954
-20% -$303K 0.39% 74
2020
Q1 		$1.47M Buy
+19,592
New +$1.35M 0.44% 68

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Transcend Capital Advisors's GILD Position: Q1 2026 in Review

Transcend Capital Advisors increased its Gilead Sciences (GILD) stake by 2% in Q1 2026, buying an estimated $17.9K and bringing the position to 6,633 shares worth $924K. The position accounts for 0.07% of the portfolio, ranked #247.

Transcend Capital Advisors first reported a position in GILD in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.14M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Transcend Capital Advisors held 6,633 shares of Gilead Sciences worth $924K as of Q1 2026.
  • Transcend Capital Advisors bought 128 Gilead Sciences shares in Q1 2026, an estimated $17.9K.
  • Gilead Sciences made up 0.07% of Transcend Capital Advisors's portfolio in Q1 2026, its #247 holding.
  • Transcend Capital Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Gilead Sciences position peaked at $2.14M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.